Skip to main content
Search
Explore journals
Get published
About BMC
My account
Search all BMC articles
Search
Critical Care
Home
About
Articles
Submission Guidelines
Table 1 Percentage of patients with supraventricular tachycardia (SVT), ventricular tachycardia (VT) or increase in premature ventricular complexes (PCV) after receiving levosimendan or placebo
From:
Effects of levosimendan on cardiac arrhythmia in patients with severe heart failure
SVT
VT
Increase in PCV
Levosimendan
5%
12%
8%
Placebo
5%
15%
9%
Back to article page